Search results

One of the major concerns with the disease caused by Covid-19 is its severe course, which causes many problems that can lead to hospital overload. Early detection of whether or not a person is at risk of developing a severe form of the disease is therefore crucial to optimise patient care and hospital resource management. This is one of the objectives of the study carried out by QUALIblood, a UNamur spin-off, in collaboration with the Department of Pharmacy and many other industrial and hospital partners. Exploration of a cutting-edge technology at the service of health.

Arcadia is the name of an ideal society, a bucolic utopia. But it is also the name chosen by the members of a brand-new research centre at UNamur. This centre, created within the Faculty of Philosophy and Letters and attached to the ESPHIN institute, questions three themes at the heart of our contemporaneity: the Anthropocene, history and utopias.

A team of microbiology researchers from UNamur has just published in the journal Nature Communications. The work focuses on the Brucella bacterium that causes Brucellosis, a disease that infects livestock and can be transmitted to humans. This research aims to better understand the molecular mechanisms of the bacterium's growth in order to better combat it.

As the largest and heaviest organ in the human body, the skin is the focus of Professor Yves Poumay's research. For nearly 30 years, within the Cells and Tissues laboratory (LabCeTi), he has been developing in vitro epidermal models that reproduce skin pathologies to better understand and treat them. A pioneering approach that offers alternatives to animal experimentation! On the eve of an international congress devoted to dermatology research organised at UNamur (see below), he talks about the importance of melanoma screening and details the latest advances in dermatology made in his laboratory.

Since the pandemic, this cry of alarm from the Nobel Prize in Economics, Jean Tirole, seems more relevant than ever. On 19 and 20 May 2022, the second Summit of the Common Good, organised in Toulouse, mobilised hundreds of thousands of internet users. On 24 May 2022, in Brussels, the Night of the Common Good raised over half a million euros in donations. And next year, the Our Lady of Peace Chair at UNamur will be dedicated to the common good. But what is this 'common good' that belongs to everyone and to no one? Four researchers from UNamur share their thoughts with us to stimulate our own.

Increasingly sophisticated technologies are invading our spheres of activity without our prior consultation as citizens. Shouldn't the new digital tools, artificial intelligence or technologies resulting from progress in neuroscience, which are transforming our identity and social relationships, be the subject of broad and sufficiently informed democratic debates? This question is at the heart of the international "research-action" project "A new humanism in the age of neuroscience and artificial intelligence" in which UNamur is participating.

Since 1996, the European Radiation Research Society (ERRS) has awarded the Bacq and Alexander Prize each year to an outstanding European researcher in recognition of the recipient's achievements in the field of radiation research. This year, the award was presented to Professor Carine Michiels, from the University of Namur.

The lysosome, a small intracellular organelle, is often represented as the stomach of the cell due to its acidity and the presence of numerous digestive enzymes within it. Its role? The degradation of numerous molecules and their recycling to build new molecules and fuel energy production in the cells. Since 2003, Marielle Boonen has been particularly interested in the lysosome. Together with researchers from UNamur, she has highlighted the role of a lysosomal enzyme called HYAL1 in the bone remodelling process.

In the summer of 2022, we set out to discover the qualified researchers at UNamur who were awarded funding by the FNRS in 2022. Today, we meet Alison Forrester, currently a postdoctoral researcher at the Institut Curie (Paris), who will soon be joining UNamur for her new term as an FNRS qualified researcher at the NARILIS Institute. Her research focuses on studying compounds that could modify the efficiency of the protein production process and thus open up new therapeutic approaches.

When a tumour develops in an organism, it is very common for the cancer cells to leave the tumour and move to another organ where they proliferate, creating what are known as metastases. This process is an important factor in mortality, as it means that the disease worsens. Hence the interest in better understanding what happens during this phenomenon. This is what the multidisciplinary team of Carine Michiels, researcher at the NARILIS Institute of UNamur, and Davide Bonifazi, researcher at the University of Vienna, did in the framework of the PACMAN research project financed by the FNRS. The results of this study are published in the journal Neoplasia.